Literature DB >> 17425813

Urethral pain syndrome and its management.

Hervinder Kaur1, Angamuthu S Arunkalaivanan.   

Abstract

UNLABELLED: Urethral pain syndrome is occurrence of persistent or recurrent episodic urethral pain usually on voiding with daytime frequency and nocturia, in the absence of proven infection or other obvious pathology. This is a condition of uncertain etiology. The objective of this article is to review etiology, diagnosis, and management of urethral pain syndrome. Since there is paucity of information on randomized trials, search of published literature has been made using keywords such as "urethral pain syndrome", "painful bladder syndrome", "urethral stenosis", and "lower urinary tract symptoms". Urethral pain syndrome is a disease of ambiguous etiology. Diagnosis is mainly based upon symptoms, and investigations are aimed to exclude other conditions affecting lower urinary tract. Various modalities of treatment including antibiotics, alpha-blockers, acupuncture, and laser therapy have been proved successful. Psychological support is very important in this group of women. Management requires multidisciplinary approach, and treatment at its best is by trial and error. TARGET AUDIENCE: Obstetricians & Gynecologists, Family Physicians. LEARNING
OBJECTIVES: After completion of this article, the reader should be able to explain that the urethral pain syndrome (UPS) has specific signs and symptoms without specific responses to a variety of treatment options and recall that treatment may require a multidisciplinary approach and a lot of sensitivity by the physician.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17425813     DOI: 10.1097/01.ogx.0000261645.12099.2a

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  6 in total

Review 1.  [Urethral pain syndrome: fact or fiction--an update].

Authors:  N M Dreger; S Degener; S Roth; A S Brandt; D A Lazica
Journal:  Urologe A       Date:  2015-09       Impact factor: 0.639

2.  Urothelial mucosal signaling and the overactive bladder-ICI-RS 2013.

Authors:  Lori A Birder; Karl-Erik Andersson; Anthony J Kanai; Ann T Hanna-Mitchell; Chris H Fry
Journal:  Neurourol Urodyn       Date:  2014-05-16       Impact factor: 2.696

Review 3.  Fundamentals and clinical perspective of urethral sphincter instability as a contributing factor in patients with lower urinary tract dysfunction--ICI-RS 2014.

Authors:  Ruth Kirschner-Hermanns; Ralf Anding; Peter Rosier; Lori Birder; Karl Erik Andersson; Jens Christian Djurhuus
Journal:  Neurourol Urodyn       Date:  2016-02       Impact factor: 2.696

4.  Efficacy of sertraline and gabapentin in the treatment of urethral pain syndrome: retrospective results of a single institutional cohort.

Authors:  Özer Ural Cakici; Nurullah Hamidi; Emre Ürer; Emrah Okulu; Onder Kayigil
Journal:  Cent European J Urol       Date:  2017-01-16

5.  Female chronic posterior urethritis is underestimated in patients with lower urinary tract symptoms.

Authors:  Juanjuan Xie; Xin Li; Yufang Lü; Caisheng Huang; Xinyang Long; Yong Liu; Huaxiang Lu; Jianhua Long; Bo Chen; Zhigang Luo; Zengnan Mo
Journal:  Transl Androl Urol       Date:  2021-08

6.  Treatment of Urethral Pain Syndrome (UPS) in Sweden.

Authors:  Lina Birgitta Ivarsson; Björn Erik Lindström; Matts Olovsson; Annika Kristina Lindström
Journal:  PLoS One       Date:  2019-11-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.